DBG-3A Dihexyl Mesylate - Request Quote
DBG-3A Dihexyl Mesylate
| SZ CAT No: | SZ-D012055 |
| CAS No | NA |
| Mol.F. | C41H55N7O8 : CH4O3S |
| Mol.Wt. | 773.9 : 96.1 |
| Inv. Status | Out of Stock |
| Rel. CAS No | 1643392-59-9 (Free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
DBG-3A Dihexyl Mesylate is chemically Ethyl (Z)-3-(3-(((hexyloxy)carbonyl)amino)-4-(2-((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)-N-methylacetamido)-N-(pyridin-2-yl)benzamido)propanoate methanesulfonate. DBG-3A Dihexyl Mesylate is supplied with detailed characterization data compliant with regulatory guideline. DBG-3A Dihexyl Mesylate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality DBG-3A Dihexyl Mesylate
Purchase DBG-3A Dihexyl Mesylate
DBG-3A Dihexyl Mesylate suppliers
DBG-3A Dihexyl Mesylate manufacturers
DBG-3A Dihexyl Mesylate price
Order DBG-3A Dihexyl Mesylate
Enquire DBG-3A Dihexyl Mesylate
DBG-3A Dihexyl Mesylate cost
DBG-3A Dihexyl Mesylate Supplier
DBG-3A Dihexyl Mesylate Distributor
DBG-3A Dihexyl Mesylate for Method Validation
Dabigatran Reference Standard
DBG-3A Dihexyl Mesylate for ANDA Filing
DBG-3A Dihexyl Mesylate for Forced Degradation Studies
DBG-3A Dihexyl Mesylate Identification Standards
DBG-3A Dihexyl Mesylate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


